Bie, S. de

vaccine patient study children pandemic fluenza event exercise nsaid safety adjuvanted strategy control nsaid users dispersion prescription report vaccination change fluenza vaccine rofecoxib withdrawal fi rst dose country fluenza vaccines fallot factor group peak exercise qrs duration rofecoxib duration database withdrawal adolescent arrhythmia reaction result number 7.5 fever population jtc dispersion –17 heart month table increase signi coxib repair european tetralogy netherland difference under-use h 1n vaccine health identi fied 6 months nsaid prescription volume guillain –barr syndrome van den berg age groups reactogenicity signi ficantly disease italy immunogenicity surveillance 1.9 pharmacol monovalent aliment pharmacol parameter monitoring europe person analysis identi